20240827 Shanghai Pharmaceutical Investor Relations Activity Record Form (Results Meeting) -mark
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on losartan potassium hydrochlorothiazide tablets passing the generic drug consistency evaluation
Announcement of Resolutions of the Thirteenth Meeting of the Eighth Board of Directors of Sh Pharma Group Co., Ltd.
Shanghai Pharma Group Co., Ltd.'s report on the continued risk assessment of Shanghai Shangshi Group Financial Co., Ltd.'s 2024 semi-annual period.
Announcement on the holding of the 2024 interim performance presentation of SH Pharma Group Co., Ltd.
Announcement from SH Pharma on the Consistency Evaluation of Generic Cobamamide Tablets.
Shanghai Pharmaceuticals Holding: Announcement from SH Pharma Group Co., Ltd. regarding the approval of production of tramadol hydrochloride tablets.
Record table of Shanghai Pharma's investor relations activities in 202406
Announcement from sh pharma on the consistency evaluation of generic bupivacaine hydrochloride injection.
Announcement of the Resolution of the Twelfth Meeting of the Eighth Board of Directors of sh pharma Group Co., Ltd.
Announcement Regarding the Consistent Evaluation of Dapantinib Tablets for Generic Drugs by SH Pharma Group Co., Ltd.
Announcement of the resolution of the seventh meeting of the eighth session of the board of supervisors of SH Pharma Group Co., Ltd.
Announcement of Resolutions of the 10th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
202405 Shanghai Pharmaceutical Investor Relations Activity Record Form - v2
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on holding a performance briefing for the first quarter of 2024
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on metoclopramide hydrochloride injection passing the generic drug consistency evaluation
Announcement of Resolutions of the 9th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
20240409 Shanghai Pharmaceutical Investor Relations Activity Record Form - Hong Kong Roadshow
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on rabeprazole sodium enteric tablets passing the generic drug consistency evaluation
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on Lorazepam tablets passing the generic drug consistency evaluation
No Data
No Data